Can Intrapleural Tissue Plasminogen Activator and Deoxyribonuclease Be Used to Treat Persistent Hemothorax After Robotic Lobectomy? [PDF]
Vivekanandan DD +3 more
europepmc +1 more source
Intrapleural tissue plasminogen activator and deoxyribonuclease in complex pleural effusion and empyema, clinical outcomes, and predictors. [PDF]
Sedhai YR +11 more
europepmc +1 more source
Tissue plasminogen activator associated pulmonary hemorrhage in patient with ACTA2-associated arteriopathy. [PDF]
Hughes TG, Wurth MA, Sheppard MB.
europepmc +1 more source
Endovascular thrombectomy versus intravenous tissue plasminogen activator for vertebrobasilar stroke treatment: insights from the national inpatient sample. [PDF]
Saha R +6 more
europepmc +1 more source
A meta-analysis on racial disparity in administration of tissue plasminogen activator (tPA) in stroke patients. [PDF]
Larik MO, Bhattarai P.
europepmc +1 more source
FIBRINOLYTIC ACTNITY IN INFLAMATORY BOWEL DISEASE
Uğur YILMAZ +5 more
doaj
Tissue Plasminogen Activator in Acute Cardiac Arrest. [PDF]
Acharya I, DeBoer SR, Haas CJ.
europepmc +1 more source
Ultrasound-mediated catheter delivery of tissue plasminogen activator promotes thrombolysis by altering fibrin fiber thickness and clot permeability. [PDF]
Ariëns RAS, Sharp ASP, Duval C.
europepmc +1 more source
Plasma tissue plasminogen activator-inhibitor complex levels in acute myocardial infarction patients: an observational study. [PDF]
Feng YF +5 more
europepmc +1 more source
Correction: Usefulness of carotid duplex ultrasonography in predicting residual large-vessel occlusions after intravenous recombinant tissue plasminogen activator therapy in patients with acute ischemic stroke. [PDF]
Kaburagi K +9 more
europepmc +1 more source

